vs
艾仕得（AXTA）与Rollins, Inc.（ROL）财务数据对比。点击上方公司名可切换其他公司
艾仕得的季度营收约是Rollins, Inc.的5.6倍（$5.1B vs $906.4M），Rollins, Inc.净利率更高（11.9% vs 1.8%，领先10.1%），Rollins, Inc.同比增速更快（10.2% vs -0.6%），Rollins, Inc.自由现金流更多（$111.2M vs $21.0M），过去两年艾仕得的营收复合增速更高（94.5% vs 0.8%）
艾仕得是源自美国的专业涂料供应商，总部位于宾夕法尼亚州费城，注册地为百慕大。公司主营乘用车、商用车、工业场景及修补用途涂料的研发与生产，业务覆盖全球130个国家，拥有近1.3万名员工，服务超10万家客户。
Rollins, Inc.是北美知名虫害防治服务商，面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务，覆盖北美、英国等市场，在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
AXTA vs ROL — 直观对比
营收规模更大
AXTA
是对方的5.6倍
$906.4M
营收增速更快
ROL
高出10.8%
-0.6%
净利率更高
ROL
高出10.1%
1.8%
自由现金流更多
ROL
多$90.2M
$21.0M
两年增速更快
AXTA
近两年复合增速
0.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $5.1B | $906.4M |
| 净利润 | $91.0M | $107.8M |
| 毛利率 | 83.6% | — |
| 营业利润率 | 2.9% | 16.1% |
| 净利率 | 1.8% | 11.9% |
| 营收同比 | -0.6% | 10.2% |
| 净利润同比 | -9.1% | 2.5% |
| 每股收益（稀释后） | $0.42 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXTAROL
| Q1 26 | $5.1B | $906.4M | ||
| Q4 25 | $1.3B | $912.9M | ||
| Q3 25 | $1.3B | $1.0B | ||
| Q2 25 | $1.3B | $999.5M | ||
| Q1 25 | $1.3B | $822.5M | ||
| Q4 24 | $1.3B | $832.2M | ||
| Q3 24 | $1.3B | $916.3M | ||
| Q2 24 | $1.4B | $891.9M |
净利润AXTAROL
| Q1 26 | $91.0M | $107.8M | ||
| Q4 25 | $60.0M | $116.4M | ||
| Q3 25 | $110.0M | $163.5M | ||
| Q2 25 | $109.0M | $141.5M | ||
| Q1 25 | $99.0M | $105.2M | ||
| Q4 24 | $137.0M | $105.7M | ||
| Q3 24 | $101.0M | $136.9M | ||
| Q2 24 | $112.0M | $129.4M |
毛利率AXTAROL
| Q1 26 | 83.6% | — | ||
| Q4 25 | 33.4% | — | ||
| Q3 25 | 34.9% | — | ||
| Q2 25 | 35.0% | — | ||
| Q1 25 | 34.3% | — | ||
| Q4 24 | 34.1% | — | ||
| Q3 24 | 35.0% | — | ||
| Q2 24 | 34.0% | — |
营业利润率AXTAROL
| Q1 26 | 2.9% | 16.1% | ||
| Q4 25 | 12.8% | 17.5% | ||
| Q3 25 | 15.8% | 21.9% | ||
| Q2 25 | 14.8% | 19.8% | ||
| Q1 25 | 13.9% | 17.3% | ||
| Q4 24 | 14.3% | 18.1% | ||
| Q3 24 | 14.6% | 20.9% | ||
| Q2 24 | 15.2% | 20.4% |
净利率AXTAROL
| Q1 26 | 1.8% | 11.9% | ||
| Q4 25 | 4.8% | 12.8% | ||
| Q3 25 | 8.5% | 15.9% | ||
| Q2 25 | 8.4% | 14.2% | ||
| Q1 25 | 7.8% | 12.8% | ||
| Q4 24 | 10.5% | 12.7% | ||
| Q3 24 | 7.7% | 14.9% | ||
| Q2 24 | 8.3% | 14.5% |
每股收益（稀释后）AXTAROL
| Q1 26 | $0.42 | $0.22 | ||
| Q4 25 | $0.28 | $0.24 | ||
| Q3 25 | $0.51 | $0.34 | ||
| Q2 25 | $0.50 | $0.29 | ||
| Q1 25 | $0.45 | $0.22 | ||
| Q4 24 | $0.63 | $0.22 | ||
| Q3 24 | $0.46 | $0.28 | ||
| Q2 24 | $0.51 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $608.0M | $116.5M |
| 总债务越低越好 | $3.1B | $650.6M |
| 股东权益账面价值 | $2.5B | $1.4B |
| 总资产 | $7.6B | $3.2B |
| 负债/权益比越低杠杆越低 | 1.27× | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资AXTAROL
| Q1 26 | $608.0M | $116.5M | ||
| Q4 25 | $657.0M | $100.0M | ||
| Q3 25 | $606.0M | $127.4M | ||
| Q2 25 | $625.0M | $123.0M | ||
| Q1 25 | $575.0M | $201.2M | ||
| Q4 24 | $593.0M | $89.6M | ||
| Q3 24 | $567.0M | $95.3M | ||
| Q2 24 | $840.0M | $106.7M |
总债务AXTAROL
| Q1 26 | $3.1B | $650.6M | ||
| Q4 25 | $3.2B | $486.1M | ||
| Q3 25 | $3.4B | $485.7M | ||
| Q2 25 | $3.4B | $485.3M | ||
| Q1 25 | $3.4B | $485.5M | ||
| Q4 24 | $3.4B | $395.3M | ||
| Q3 24 | $3.5B | — | ||
| Q2 24 | $3.6B | — |
股东权益AXTAROL
| Q1 26 | $2.5B | $1.4B | ||
| Q4 25 | $2.3B | $1.4B | ||
| Q3 25 | $2.3B | $1.5B | ||
| Q2 25 | $2.3B | $1.4B | ||
| Q1 25 | $2.1B | $1.4B | ||
| Q4 24 | $1.9B | $1.3B | ||
| Q3 24 | $1.9B | $1.3B | ||
| Q2 24 | $1.8B | $1.2B |
总资产AXTAROL
| Q1 26 | $7.6B | $3.2B | ||
| Q4 25 | $7.6B | $3.1B | ||
| Q3 25 | $7.8B | $3.2B | ||
| Q2 25 | $7.8B | $3.2B | ||
| Q1 25 | $7.4B | $2.9B | ||
| Q4 24 | $7.2B | $2.8B | ||
| Q3 24 | $7.5B | $2.8B | ||
| Q2 24 | $7.3B | $2.8B |
负债/权益比AXTAROL
| Q1 26 | 1.27× | 0.47× | ||
| Q4 25 | 1.36× | 0.35× | ||
| Q3 25 | 1.48× | 0.32× | ||
| Q2 25 | 1.50× | 0.34× | ||
| Q1 25 | 1.64× | 0.36× | ||
| Q4 24 | 1.78× | 0.30× | ||
| Q3 24 | 1.84× | — | ||
| Q2 24 | 2.02× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $118.4M |
| 自由现金流经营现金流 - 资本支出 | $21.0M | $111.2M |
| 自由现金流率自由现金流/营收 | 0.4% | 12.3% |
| 资本支出强度资本支出/营收 | — | 0.8% |
| 现金转化率经营现金流/净利润 | — | 1.10× |
| 过去12个月自由现金流最近4个季度 | $491.0M | $621.1M |
8季度趋势，按日历期对齐
经营现金流AXTAROL
| Q1 26 | — | $118.4M | ||
| Q4 25 | $344.0M | $164.7M | ||
| Q3 25 | $137.0M | $191.3M | ||
| Q2 25 | $142.0M | $175.1M | ||
| Q1 25 | $26.0M | $146.9M | ||
| Q4 24 | $234.0M | $188.2M | ||
| Q3 24 | $194.0M | $146.9M | ||
| Q2 24 | $114.0M | $145.1M |
自由现金流AXTAROL
| Q1 26 | $21.0M | $111.2M | ||
| Q4 25 | $286.0M | $159.0M | ||
| Q3 25 | $87.0M | $182.8M | ||
| Q2 25 | $97.0M | $168.0M | ||
| Q1 25 | $-17.0M | $140.1M | ||
| Q4 24 | $172.0M | $184.0M | ||
| Q3 24 | $161.0M | $139.4M | ||
| Q2 24 | $91.0M | $136.4M |
自由现金流率AXTAROL
| Q1 26 | 0.4% | 12.3% | ||
| Q4 25 | 22.7% | 17.4% | ||
| Q3 25 | 6.8% | 17.8% | ||
| Q2 25 | 7.4% | 16.8% | ||
| Q1 25 | -1.3% | 17.0% | ||
| Q4 24 | 13.1% | 22.1% | ||
| Q3 24 | 12.2% | 15.2% | ||
| Q2 24 | 6.7% | 15.3% |
资本支出强度AXTAROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | 4.6% | 0.6% | ||
| Q3 25 | 3.9% | 0.8% | ||
| Q2 25 | 3.4% | 0.7% | ||
| Q1 25 | 3.4% | 0.8% | ||
| Q4 24 | 4.7% | 0.5% | ||
| Q3 24 | 2.5% | 0.8% | ||
| Q2 24 | 1.7% | 1.0% |
现金转化率AXTAROL
| Q1 26 | — | 1.10× | ||
| Q4 25 | 5.73× | 1.41× | ||
| Q3 25 | 1.25× | 1.17× | ||
| Q2 25 | 1.30× | 1.24× | ||
| Q1 25 | 0.26× | 1.40× | ||
| Q4 24 | 1.71× | 1.78× | ||
| Q3 24 | 1.92× | 1.07× | ||
| Q2 24 | 1.02× | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
